DK139717B - Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof. - Google Patents
Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof.Info
- Publication number
- DK139717B DK139717B DK401270AA DK401270A DK139717B DK 139717 B DK139717 B DK 139717B DK 401270A A DK401270A A DK 401270AA DK 401270 A DK401270 A DK 401270A DK 139717 B DK139717 B DK 139717B
- Authority
- DK
- Denmark
- Prior art keywords
- aminoalkoxystyroles
- beta
- aryl
- preparation
- acid addition
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
- C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
- C07C39/20—Hydroxy-styrenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Illuminated Signs And Luminous Advertising (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1939809A DE1939809B2 (en) | 1969-08-05 | 1969-08-05 | β-Aryl-2-aminoalkoxy-styrenes and process for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DK139717B true DK139717B (en) | 1979-04-02 |
DK139717C DK139717C (en) | 1979-09-17 |
Family
ID=5741970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK401270AA DK139717B (en) | 1969-08-05 | 1970-08-04 | Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof. |
Country Status (25)
Country | Link |
---|---|
JP (6) | JPS4941433B1 (en) |
KR (1) | KR780000113B1 (en) |
AT (5) | AT302346B (en) |
BE (1) | BE754405A (en) |
BG (6) | BG18599A3 (en) |
CH (6) | CH548981A (en) |
CS (6) | CS170538B2 (en) |
DE (1) | DE1939809B2 (en) |
DK (1) | DK139717B (en) |
ES (6) | ES382426A1 (en) |
FI (1) | FI54912C (en) |
FR (1) | FR2068463B1 (en) |
GB (1) | GB1307436A (en) |
HU (1) | HU163185B (en) |
IE (1) | IE34634B1 (en) |
IL (1) | IL35047A (en) |
NL (1) | NL7011590A (en) |
NO (1) | NO135243C (en) |
PH (1) | PH9520A (en) |
PL (2) | PL78370B1 (en) |
RO (5) | RO57793A (en) |
SE (1) | SE382211B (en) |
SU (3) | SU450398A3 (en) |
YU (2) | YU198170A (en) |
ZA (1) | ZA705411B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50139537A (en) * | 1974-04-25 | 1975-11-07 | ||
US4220603A (en) * | 1977-10-07 | 1980-09-02 | Mitsubishi Chemical Industries, Limited | Pharmaceutically active (omega-aminoalkoxy)bibenzyls |
JPS6045632B2 (en) * | 1978-03-09 | 1985-10-11 | 三菱化学株式会社 | ω-aminoalkoxystilbenes and their acid addition salts |
DE2818765A1 (en) | 1978-04-28 | 1979-11-08 | Basf Ag | AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE |
DE2818998A1 (en) * | 1978-04-29 | 1979-11-15 | Basf Ag | 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES AND METHOD FOR THE PRODUCTION THEREOF |
DE2818999A1 (en) * | 1978-04-29 | 1979-11-15 | Basf Ag | AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXYSTYRYL) -ISOXAZOLES |
JPS5629548A (en) * | 1979-08-16 | 1981-03-24 | Mitsubishi Chem Ind Ltd | Omega-aminoalkoxystilbenes and their acid addition salts |
DE2943406A1 (en) | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL |
DE2943405A1 (en) * | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | NEW AMINO DERIVATIVES OF 5- (2-HYDROXYSTYRYL) -ISOXAZOLE |
DE3006809A1 (en) * | 1980-02-23 | 1981-09-24 | Basf Ag, 6700 Ludwigshafen | 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
JPS5874379U (en) * | 1981-11-16 | 1983-05-19 | 富士通株式会社 | electronic equipment |
NO174506B (en) * | 1984-10-30 | 1994-02-07 | Usv Pharma Corp | Analogous procedure for the preparation of therapeutically active compounds |
US9468566B2 (en) | 2011-06-10 | 2016-10-18 | The Procter & Gamble Company | Absorbent structure for absorbent articles |
RU2568565C2 (en) | 2011-06-10 | 2015-11-20 | Дзе Проктер Энд Гэмбл Компани | Disposable diapers |
JP5940655B2 (en) | 2011-06-10 | 2016-06-29 | ザ プロクター アンド ギャンブル カンパニー | Absorbent core for disposable absorbent articles |
EP2740449B1 (en) | 2012-12-10 | 2019-01-23 | The Procter & Gamble Company | Absorbent article with high absorbent material content |
DE202014011107U1 (en) | 2013-06-14 | 2017-12-15 | The Procter & Gamble Company | When wet, channels forming absorbent article and absorbent core |
US9987176B2 (en) | 2013-08-27 | 2018-06-05 | The Procter & Gamble Company | Absorbent articles with channels |
EP2851048B1 (en) | 2013-09-19 | 2018-09-05 | The Procter and Gamble Company | Absorbent cores having material free areas |
ES2606320T3 (en) | 2013-12-19 | 2017-03-23 | The Procter & Gamble Company | Absorbent cores that have channel-forming areas and wrapping joints in c |
-
0
- BE BE754405D patent/BE754405A/en unknown
-
1969
- 1969-08-05 DE DE1939809A patent/DE1939809B2/en active Granted
-
1970
- 1970-07-21 FI FI2035/70A patent/FI54912C/en active
- 1970-07-22 RO RO65938A patent/RO57793A/ro unknown
- 1970-07-22 RO RO65491A patent/RO58861A2/en unknown
- 1970-07-22 RO RO64019A patent/RO57548A/ro unknown
- 1970-07-22 BG BG015253A patent/BG18599A3/en unknown
- 1970-07-22 BG BG017598A patent/BG17952A3/en unknown
- 1970-07-22 BG BG017595A patent/BG20095A3/en unknown
- 1970-07-22 RO RO65939A patent/RO57794A/ro unknown
- 1970-07-22 BG BG017596A patent/BG17950A3/en unknown
- 1970-07-22 BG BG017597A patent/BG17951A3/en unknown
- 1970-07-22 RO RO65937A patent/RO58837A/ro unknown
- 1970-07-22 BG BG017594A patent/BG18600A3/en unknown
- 1970-07-28 SU SU1701190A patent/SU450398A3/en active
- 1970-07-28 SU SU1701179A patent/SU428597A3/en active
- 1970-07-28 SU SU1701181A patent/SU432712A3/ru active
- 1970-07-30 KR KR7001068A patent/KR780000113B1/en active
- 1970-07-31 CS CS3514*[A patent/CS170538B2/cs unknown
- 1970-07-31 CS CS3511*[A patent/CS170535B2/cs unknown
- 1970-07-31 CS CS3510*[A patent/CS170534B2/cs unknown
- 1970-07-31 CS CS3512*[A patent/CS170536B2/cs unknown
- 1970-07-31 CS CS3513*[A patent/CS170537B2/cs unknown
- 1970-07-31 CS CS5391A patent/CS170533B2/cs unknown
- 1970-08-03 JP JP45067958A patent/JPS4941433B1/ja active Pending
- 1970-08-03 HU HUTO819A patent/HU163185B/hu unknown
- 1970-08-04 ES ES382426A patent/ES382426A1/en not_active Expired
- 1970-08-04 ES ES382425A patent/ES382425A1/en not_active Expired
- 1970-08-04 ES ES382428A patent/ES382428A1/en not_active Expired
- 1970-08-04 GB GB3766370A patent/GB1307436A/en not_active Expired
- 1970-08-04 PH PH11713*UA patent/PH9520A/en unknown
- 1970-08-04 PL PL1970142516A patent/PL78370B1/pl unknown
- 1970-08-04 IE IE998/70A patent/IE34634B1/en unknown
- 1970-08-04 ES ES382427A patent/ES382427A1/en not_active Expired
- 1970-08-04 IL IL35047A patent/IL35047A/en unknown
- 1970-08-04 PL PL1970175377A patent/PL93130B1/pl unknown
- 1970-08-04 ES ES382430A patent/ES382430A1/en not_active Expired
- 1970-08-04 DK DK401270AA patent/DK139717B/en unknown
- 1970-08-04 YU YU01981/70A patent/YU198170A/en unknown
- 1970-08-04 CH CH147873A patent/CH548981A/en not_active IP Right Cessation
- 1970-08-04 CH CH148273A patent/CH548983A/en not_active IP Right Cessation
- 1970-08-04 ES ES382429A patent/ES382429A1/en not_active Expired
- 1970-08-04 CH CH148073A patent/CH548368A/en not_active IP Right Cessation
- 1970-08-04 CH CH147973A patent/CH548367A/en not_active IP Right Cessation
- 1970-08-04 NO NO3005/70A patent/NO135243C/no unknown
- 1970-08-04 CH CH148173A patent/CH548982A/en not_active IP Right Cessation
- 1970-08-04 CH CH1172670A patent/CH548366A/en not_active IP Right Cessation
- 1970-08-05 AT AT943371A patent/AT302346B/en not_active IP Right Cessation
- 1970-08-05 FR FR7028941A patent/FR2068463B1/fr not_active Expired
- 1970-08-05 AT AT713970A patent/AT301565B/en not_active IP Right Cessation
- 1970-08-05 AT AT943071A patent/AT302344B/en not_active IP Right Cessation
- 1970-08-05 AT AT943171A patent/AT302345B/en not_active IP Right Cessation
- 1970-08-05 AT AT943271A patent/AT303055B/en not_active IP Right Cessation
- 1970-08-05 ZA ZA705411A patent/ZA705411B/en unknown
- 1970-08-05 SE SE7010773A patent/SE382211B/en unknown
- 1970-08-05 NL NL7011590A patent/NL7011590A/xx not_active Application Discontinuation
-
1973
- 1973-11-29 JP JP48133939A patent/JPS5113148B1/ja active Pending
- 1973-11-29 JP JP48133937A patent/JPS5113146B1/ja active Pending
- 1973-11-29 JP JP48133941A patent/JPS5113150B1/ja active Pending
- 1973-11-29 JP JP48133940A patent/JPS5113149B1/ja active Pending
- 1973-11-29 JP JP48133938A patent/JPS5113147B1/ja active Pending
-
1978
- 1978-02-17 YU YU00374/78A patent/YU37478A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK134984B (en) | Analogous process for the preparation of alpha-alkylaminopropiophenones or acid addition salts thereof. | |
DK124884B (en) | Analogous process for the preparation of 2-bromo-α-ergocryptine or acid addition salts thereof. | |
DK129446B (en) | Analogous process for the preparation of phenoxyhydroxypropylamines or acid addition salts thereof. | |
DK127556B (en) | Analogous process for the preparation of quinazoline derivatives or acid addition salts thereof. | |
DK139869B (en) | Analogous process for the preparation of phenyl-imidazolyl-alkanoic acid derivatives or salts thereof. | |
DK139717B (en) | Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof. | |
DK131858B (en) | Analogous process for the preparation of 4-amino-6-arylpyrimidine compounds or acid addition salts thereof. | |
DK135278B (en) | Analogous process for the preparation of phenoxyisopropanolamine derivatives or acid addition salts thereof. | |
DK136526B (en) | Analogous process for the preparation of substituted naphthylalkylamines or acid addition salts thereof. | |
DK129577B (en) | Analogous process for the preparation of phenacetylguanidines or acid addition salts thereof. | |
DK127644B (en) | Analogous process for the preparation of ergopeptins or acid addition salts thereof. | |
DK125245B (en) | Process for the preparation of γpiperidinobutyrophenone derivatives or acid addition salts thereof. | |
DK129346B (en) | Analogous process for the preparation of imidazole derivatives or acid addition salts thereof. | |
DK125472B (en) | Analogous process for the preparation of pyrimidopyridazine derivatives or acid addition salts thereof. | |
DK120155B (en) | Analogous process for the preparation of aminopropiophenones or acid addition salts thereof. | |
DK138015B (en) | Process for the preparation of substituted N-cycloalkyl-arylamino-imidazolines (2) or acid addition salts thereof. | |
DK129454B (en) | Analogous process for the preparation of ergonorcornine or acid addition salts thereof. | |
DK127424B (en) | Analogous process for the preparation of 4-aryl-1- (4,4-diarylbutyl) -4-hydroxypiperidines or acid addition salts thereof. | |
DK136151B (en) | Analogous process for the preparation of basic substituted tertiary butanols or acid addition salts thereof. | |
DK129164B (en) | Analogous process for the preparation of 3-alkyl-5-aryloxymethylisoxazoles or acid addition salts thereof. | |
DK131727B (en) | Analogous process for the preparation of oxazinobenzoxazines or acid addition salts thereof. | |
DK127642B (en) | Analogous process for the preparation of benzodioxane derivatives or acid addition salts thereof. | |
DK131147B (en) | Process for the preparation of butyrophenone derivatives or acid addition salts thereof. | |
DK134023B (en) | Analogous process for the preparation of acyloxypiperazinyl compounds or acid addition salts thereof. | |
DK137834B (en) | Analogous process for the preparation of triazolobenzodiazepine derivatives or acid addition salts thereof. |